Editors' Pick
Papers: 9 Apr 2012 - 16 Apr 2012
Centre d'Etude, de Ressource et de Veille en Neuropathologie (CERVEN) de la Salpêtrière, Paris
Université Pierre et Marie Curie, Paris
NeuroBioTec
Biological Resource Centre (BRC) of Hospices Civils de Lyon (HCL)
BrainNet Europe
BrainNet Europe
Papers: 2 Apr 2012 - 9 Apr 2012
Choosing Therapies
We currently have approximately a dozen disease modifying therapies. What is the rationale behind choice of therapy...
"While I know that reducing relapse rates hopefully slows disability progression, can we please do a bit more to remember those who don't have relapses. Sometimes it seems like if… Read"
Altered Immunity, Crippled Neurons
Widespread physiological malfunctions underlie MS
Putting out a fire stops a house from burning, but if the underlying cause is...
Drug Development, Laboratory Research
Gate Crashers
Vascular barriers and multiple sclerosis
Ask most neurologists what part of the body breaks down in multiple sclerosis and they’ll say...
Drug Development, Laboratory Research
Animal Arsenal: An overview of animal models that mimic key aspects of MS
Pages
